Cart
sales@molnova.com
RORγ inverse agonist 1
CAS No. 529500-72-9
RORγ inverse agonist 1( —— )
Catalog No. M36101 CAS No. 529500-72-9
RORγ inverse agonist 1 has anti-inflammatory activity and can be used to treat rheumatism and psoriasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 30 | In Stock |
|
| 25MG | 50 | In Stock |
|
| 50MG | 73 | In Stock |
|
| 100MG | 109 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRORγ inverse agonist 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionRORγ inverse agonist 1 has anti-inflammatory activity and can be used to treat rheumatism and psoriasis.
-
DescriptionRORγ inverse agonist 1 is the inverse agonist of RORγ.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number529500-72-9
-
Formula Weight463.47
-
Molecular FormulaC22H20F3N3O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(S(=O)(=O)C1=CC=C(C)C=C1)(CC(NCC=2C=CN=CC2)=O)C3=CC(C(F)(F)F)=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Song Y, et al. Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation. Eur J Med Chem. 2016 Jun 30;116:13-26.?
molnova catalog
related products
-
Neoprocurcumenol
Neoprocurcumenol is a larvicidal compound that exerts significant toxicity on mosquito larvae with LC50 and LC 90 values of 13.69 and 23.92 ppm, respectively.
-
Mocravimod hydrochlo...
Mocravimod hydrochloride is an effecitive and orally active agonist of sphingosine 1-phosphate receptor type 1(S1PR1).
-
Uroguanylin (human)
Uroguanylin (human) is a natural ligand for the Guanylyl Cyclase (GCC) receptor expressed in metastatic colorectal cancer tumors. Uroguanylin (human) has anti-tumor actions in an animal model for human colon cancer.
